2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine

CAS : 230615-59-5

Ref. 3D-FT11984

Informations sur le produit

• Nom: 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine
• Synonymes: 7,8-Dinitro-3-(Trifluoroacetyl)-2,3,4,5-Tetrahydro-1H-1,5-Methano-3-Benzazepine, 1-(4,5-Dinitro-10-Aza-Tricyclo[6.3.1.0]Dodeca-2,4,6-Trien-10-Yl)-2,2,2-Trifluoro-Ethanone, Ethanone, 2,2,2-trifluoro-1-(1,2,4,5-tetrahydro-7,8-dinitro-1,5-methano-3H-3-benzazepin-3-yl)-, 1-(4,5-Dinitro-10-aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone, Varenicline Intermediate, 1-(4,5-Dinitro-10-azatricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoroethanone, 1-(7,8-dinitro-1,2,4,5-tetrahydro-3H-1,5-methano-3-benzazepin-3-yl)-2,2,2-trifluoroethanonato
• CAS: 230615-59-5

Description

2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine is a supplement that may be used to treat depression. It has been shown to have a receptor activity on the acetylcholine receptors. 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine has also been shown to increase the activity of the endothelial function by increasing the production of nitric oxide. This drug has also been shown to be an effective treatment for reducing appetite in cases of anorexia nervosa and for treating Alzheimer's disease. The drug works by activating nicotinic acetylcholine receptors in the brain.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 345.23 g/mol
• Formule: C₁₃H₁₀F₃N₃O₅
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder